|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1989-8-29
|
|
pubmed:abstractText |
A 75-year-old man developed a biopsy-proven, drug-induced intrahepatic cholestasis after use of amoxycillin trihydrate combined with the beta-lactam inhibitor potassium clavulanate (Augmentin). Cholestatic liver injury is an uncommonly recognized, probably immunologically based adverse reaction to therapy with penicillin and its derivatives.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0163-2116
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1290-3
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:2752877-Aged,
pubmed-meshheading:2752877-Amoxicillin,
pubmed-meshheading:2752877-Amoxicillin-Potassium Clavulanate Combination,
pubmed-meshheading:2752877-Cholestasis, Intrahepatic,
pubmed-meshheading:2752877-Clavulanic Acids,
pubmed-meshheading:2752877-Drug Therapy, Combination,
pubmed-meshheading:2752877-Humans,
pubmed-meshheading:2752877-Liver,
pubmed-meshheading:2752877-Male
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Amoxycillin/clavulanic acid (Augmentin)-induced intrahepatic cholestasis.
|
|
pubmed:affiliation |
Department of Gastroenterology, University College and Middlesex Hospital, Medical School, U.K.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
